Lower Drug Costs Now Act of 2019 : report of the Committee on Energy and Commerce.

Prescription drug price inflation : are prices rising too fast? : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eleventh Congress, first session, December 8, 2009.
Published: (2012)

Drug pricing and intellectual property : the legislative landscape for the 117th Congress /
by: Hickey, Kevin J., et al.
Published: (2021)

Examining the 340B drug pricing program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, March 24, 2015.
Published: (2015)

Description of the revenue provisions of H.R. 3, the "Lower Drug Costs Now Act of 2019" : scheduled for markup by the House Committee on Ways and Means on October 22, 2019 /
Published: (2019)

Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021.
Published: (2022)

Profits over consumers : exposing how pharmaceutical companies game the system : hearing before the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, September 19, 2019.
Published: (2022)

Examining how covered entities utilize the 340B drug pricing program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, October 11, 2017.
Published: (2019)

CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act /
by: Adams, Christopher P., et al.
Published: (2021)

Examining the actions of drug companies in raising prescription drug prices : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, January 29, 2019.
Published: (2019)

Priced out of a lifesaving drug : getting answers on the rising cost of insulin : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 10, 2019.
Published: (2020)

Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session.
Published: (2019)

Safeguarding pharmaceutical supply chains in a global economy : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, October 30, 2019.
Published: (2022)

Orange Book Transparency Act of 2019 : report (to accompany H.R. 1503) (including cost estimate of the Congressional Budget Office).
Published: (2019)

The price of health : the modern pharmaceutical enterprise and the betrayal of a history of care /
by: Kinch, Michael, 1966-, et al.
Published: (2021)

The complex web of prescription drug prices : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC.
Published: (2022)

Medicare Part B : enrollment and premiums /
by: Davis, Patricia A. (Specialist in Health Care Financing)
Published: (2018)

Administrative Procedure Act challenges to CMS's implementation of the Medicare Drug Price Negotiation Program /
by: Rogers, Hannah-Alise
Published: (2024)

Implementation of the Medicare Drug Price Negotiation Program : Centers for Medicare and Medicaid guidance and legal considerations /
by: Rogers, Hannah-Alise
Published: (2023)

Effective administration of the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining effective administration of the 340B Drug Pricing Program, June 19, 2018.
Published: (2020)

The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019.
Published: (2022)

Studies in pharmaceutical economics /
Published: (1996)

Priced out of a lifesaving drug : the human impact of rising insulin costs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, April 2, 2019.
Published: (2020)

CDER ... report to the nation /
Published: (1998)

Making medicine, making money /
by: Drake, Donald, 1935-
Published: (1993)

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.
Published: (2004)

International trade and pharmaceuticals : joint hearing before the Subcommittee on International Trade and the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session, April 27, 2004.
Published: (2004)

From test tube to patient : new drug development in the United States.
Published: (1995)

PBS newshour.
Published: (2023)

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, first session, August 1, 2003.
Published: (2004)

Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019.
Published: (2021)

Pharmaceutical price regulation : public perceptions, economic realities, and empirical evidence /
by: Vernon, John A.
Published: (2008)

Perspectives on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B drug discount program, March 15, 2018.
Published: (2020)

Private profits versus public policy : the pharmaceutical industry and the Canadian state /
by: Lexchin, Joel, 1948-
Published: (2016)

Prescription for the people : an activist's guide to making medicine affordable for all /
by: Quigley, Fran, 1962-
Published: (2017)